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doi:10.1016/j.jfma.2011.02.001Background/Purpose: Multimodal analgesia can improve perioperative analgesia but knowl-
edge of combination protocols is still incomplete. This study was designed to evaluate whether
the combination of sciatic nerve blockade (SNB) and intravenous alfentanil (IVA) is more effec-
tive than either single treatment in relieving postoperative pain in rats.
Methods: In a plantar incision model, withdrawal thresholds were evaluated by von Frey test
before incision as baselines and for 7 days after incision. The animals were randomly allocated
into various groups to receive SNB with 1% or 2% lidocaine, IVA of 50 or 150 mg/kg, or combined
treatments (SNB 1% þ 50 mg/kg IVA or SNB 2% þ 150 mg/kg IVA) before incision. The results were
compared with those of sham proceduresdi.e., injections of peri-sciatic or intravenous saline,
or a combination of both.
Results: Plantar incision caused postoperative allodynia for 3 days. SNB with 2% lidocaine
reduced allodynia at 1 hour, 3 hours, day 1, and day 2, but not at postoperative 5 hours or daysdicine, Fu Jen Catholic University, No. 510, Zhongzheng Rd., Xinzhuang Dist., New Taipei City, 24205
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102 Y.-R. Wen et al.3e7, whereas 150 mg/kg IVA produced short analgesia for only 3 hours after surgery. Neither
low-dose SNB nor low-dose IVA had a significant effect. When high-dose SNB and high-dose
IVA were combined, a strong antiallodynic effect was shown in an additive manner. No syner-
gism was evidently displayed by the combination.
Conclusion: Our results indicated that in an incisional pain model, multimodal analgesia is supe-
rior to single or no pretreatment; however, the combination of multimodal analgesic treatments
should be individually discerned depending on nociceptive types and analgesic mechanisms.
Copyright ª 2012, Elsevier Taiwan LLC & Formosan Medical Association. All rights reserved.Introduction
Surgical pain is a common predictable pain in hospitals.
Ineffective pain control decreases patient satisfaction,
delays hospital discharge, increases morbidity,1,2 and even
leads to chronic postsurgical pain syndrome.3 For better
pain control, multimodal analgesic techniques through
different inhibitory pathways at the perioperative period
were suggested by studies4 and by the Guidelines for Acute
Pain Management by ASA Task Force.5 Nevertheless, the
Guideline did not recommend any optimal combination
protocols. Although single or multiple analgesic techniques
have all been widely investigated,6 it is still difficult to
predict their actions on a distinct pain quality because the
mostly used pain measurement in clinical studies, such as
visual analog scale, can only reflect generalized pain
perception rather than a distinct pathological reaction.
Therefore, we examined the efficacy of two mechanism-
independent modes of analgesic techniques i.e., sciatic
nerve blockade (SNB) and intravenous opioid, administered
separately or in combination, on reduction of mechanical
pain in a rat plantar incision (PI) model. Postoperative
mechanical hypersensitivity is a common problem directly
interfering with postsurgical movements, wound dressing
changes, and daily rehabilitation. Mechanical allodynia is
an objective sign indicating a specific nociceptive sensiti-
zation in a prolonged pathological process after tissue
injury, and can be quantitatively measured by tactile-
responsive tests. This sign can be more easily accessed in
animals than in humans, because infection at surgical
wound is less concerned. Meanwhile, lidocaine, a popular
local anesthetic with a pharmacologically short action, and
alfentanil, a pure m-receptor agonist similar to fentanyl but
with a much shorter effect, are selected, because the
surgical period is short in this study (about 5 minutes). We
intentionally included the two agents to test our hypoth-
esisdwhether combining two efficacious but short-acting
i.e., only intraoperatively effective, anesthetic/analgesic




Male SpragueeDawley rats (250e300 g; BioLASCO Co.,
Taipei, Taiwan) were housed in groups of three to four in
a temperature- (23  1C) and humidity- (50% relativehumidity) controlled animal room with a 12-h light/dark
cycle. Food and water were provided ad libitum. The
experiments were approved by the Animal Care and Use
Committee of Shin-Kong Wu Ho-Su Memorial Hospital and
strictly followed the ethical guidelines issued by the
International Association for the Study of Pain.7 Efforts
were made to minimize the number of rats used.
Plantar incision pain model
This model was previously reported,8,9 and had been
proven to reliably mimic human postoperative pain with
several lines of evidence.8,10,11 In brief, the plantar surface
of the left hind paw was longitudinally incised for 1 cm
under 2% isoflurane anesthesia. The plantaris muscle was
incised, leaving the origin and insertion intact. After skin
suture, the rats were moved to an elevated mesh for
behavioral testing. During the experiments, rats with
wound infection were excluded.
Behavioral responses to von Frey stimulation
Postoperative mechanical pain was evaluated by von Frey
test. Two or 3 days before PI, rats were placed in a chamber
(10  10  20 cm) of Plexiglas boxes on an elevated metal
mesh for at least 30 minutes and stimulated by von Frey
fibers for habituation. The von Frey stimulation was applied
from the mesh opening to the plantar surface near the
medial heel using the upedown method,12 with a series of
von Frey fibers (0.4, 0.6, 1, 2, 4, 6, 8, and 15 g; Stoelting,
Wood Dale, IL) starting from a 2-g fiber. The 50% threshold
at each time point was calculated and averaged from two
measurements, separated by 5 minutes.9 The time points
included a baseline obtained 1 hour before surgery and at
postoperative 1 hour, 3 hours, 5 hours, 1 day, 2 days, 3
days, 5 days, and 7 days. The experimenter for the
behavioral testing had no knowledge of the rat allocation.
Experimental design and analgesic techniques
The analgesic effects of SNB with 1% or 2% lidocaine (Lido)
or intravenous alfentanil (IVA; 50 or 150 mg/kg) were first
evaluated separately, then we examined the efficacy
of combining the two techniques in low-dose (SNB 1%
Lido þ IVA 50 mg/kg) and high-dose (SNB 2% Lido þ IVA
150 mg/kg) combinations. To avoid confounding the effects
of surgical and injection procedures, the control groups
and single-treatment groups in all experiments received
Multimodal analgesia for incision pain 103adequate sham procedures for comparison. There were
three different sham procedures: peri-sciatic saline injec-
tion, intravenous saline injection, or their combination.
Therefore, seven groups were derived, and rats were allo-
cated to different treatments (Fig. 1); (1) SNB1: SNB with
1% lidocaine followed by intravenous saline injection (i.e.,
a sham IVA); (2) SNB2: SNB with 2% lidocaine and then
sham IVA; (3) IVA50: sham SNB first, then followed by
IVA (50 mg/kg); (4) IVA150: sham SNB followed by IVA
(150 mg/kg); (5) SNB1 þ IVA50: SNB with 1% lidocaine fol-
lowed by IVA (50 mg/kg; i.e., a low-dose combination); (6)
SNB2 þ IVA150: SNB with 2% lidocaine then IVA (150 mg/kg;
i.e., a high-dose combination); (7) control sham group:
sham SNB followed by sham IVA. We always started with
SNB because it took a longer time to take effect. IVA was
administered next and took about 20 minutes, including
needle insertion and drug infusion. All treatments were
conducted under anesthesia and before PI (see Fig. 1).
Sciatic nerve blockade
The sciatic nerve was exposed via incision of the left lateral
thigh and division of the superficial fascia and muscle as
previously described.13 With a 30-G needle tuberculin
syringe, a total 100 ml of 1%, 2% lidocaine, or saline was
injected beneath the fascia at both sides of the nerve. The
injectate formed a clear bulb surrounding and outside the
perineurium without breaching it. The muscles were
sutured by layers, and the wound was closed with 3e0 silk.
PI was performed about 30 minutes after SNB.
To avoid mistaking the SNB-induced motor blockades as
an analgesic effect, the neurobehavioral tests were con-
ducted in a separate group of naı¨ve rats without PI. For
motor testing, the force of the extensor postural thrust in
the injected hind limb was evaluated as previously
described.13 The rat was held upright with the hind limbs
extended so that the toes supported its weight. The
reduction of the thrust force was estimated by the
preserved force and was converted to a score (0: baseline
or no block; 1: minimal block, force within 50e100% of
preinjection value; 2: moderate block, force below 50% of
the preinjection value but not flaccid; 3: complete block,
flaccid, and no thrust power). Meanwhile, sensory blockade
was evaluated using withdrawal reflex or vocalization in
response to a pinch of the distal phalanx of the fifth toe.Figure 1 Experimental protocols of pretreatment with
different analgesic techniques in a plantar incision (PI) model.
Sciatic nerve blockade (SNB) and intramuscular lidocaine (IML)
injection, the latter serving as a positive control of SNB, began
at 30 min before PI. Intravenous alfentanil (IVA) infusion began
at 20 min before PI. Anesthesia (horizontal thick line) stopped
immediately after PI. The time points of von Frey stimulation
are marked with black circle ().The reactions were graded on a scale (0: normal, brisk
withdrawal reflex or escape behavior, and strong vocaliza-
tion; 1: mildly impaired; 2: moderately impaired; and 3:
totally no nocifensive reaction).
Additionally, systemic lidocaine was reported to produce
an analgesic effect on incision-induced secondary allody-
nia.14 To rule out this possibility, another group of rats
received intramuscular injection with 0.5 ml of 2% lidocaine
in the right-side back muscles as a positive control. PI was
conducted 30 minutes after injections.
Intravenous alfentanil
Alfentanil hydrochloride (Rapifen; Janssen-Cilag, Beerse,
Belgium) or saline vehicle was given into the tail vein via an
inserted 30-G needle. Successful cannulation was ensured
by free backflow with blood. Alfentanil of two concentra-
tions (50 or 150 mg/ml) was infused at a rate of 25 ml/
minute, using a syringe pump (Model KDS 210; KD Scientific
Inc., New Hope, PA, USA) to final doses of 50 or 150 mg/kg,
respectively, in about 10e12 minutes. This dose was based
on a previous study of single dose alfentanil on formalin-
induced pain.15 Rats with incomplete injections were
excluded.
Statistical analysis
Data were expressed as means  standard error of the
means (SEM). Post-incision threshold changes were
compared with their baseline data (Pre) using repeated-
measures analysis of variance. Analgesic effects among the
groups at each time point were compared by one-way
analysis of variance followed by post hoc Bonferroni’s test.
The neurobehavioral blockade scores of SNB test in naı¨ve
rats are ordinal data and were expressed as medians with
first and third quartiles for nonparametric analysis. The
blockade effects over time were compared using Fried-
man’s test. A value of p < 0.05 was considered statistically
significant. At least nine rats were included in each group.
Results
PI resulted in mechanical allodynia
Incision at plantar surface of the hind paw resulted in
noxious responses to von Frey filament stimulation as shown
in the results of the control group in the present study and
previous reports.8,11 Withdrawal thresholds decreased
immediately and lasted for 3 days after surgery (the control
sham group in Figs. 2e5), indicating a persistent nocicep-
tive hypersensitivity induced by PI. On the fifth post-
operative day, mechanical responses to von Frey fibers
returned to preoperative levels.
SNB produced a moderate but prolonged analgesic
effect
Nerve block pretreatment with 1% lidocaine mildly reduced
postoperative allodynia (not statistically significant),
whereas SNB of 2% lidocaine efficaciously suppressed
incision-induced allodynia for about 2 days, with statistical
Figure 2 Effects of sciatic nerve blockade (SNB). Before PI,
rats were subjected to either SNB with 2% or 1% lidocaine
followed by intravenous saline infusion (i.e., SNB2 and SNB1).
The control rats received sham blockade with saline and IV
saline (i.e., Cont, Sham). PI produced a significant decrease of
thresholds in the control group (n Z 9) for postoperative 3
days. SNB1 (n Z 8) did not significantly meliorate mechanical
allodynia, whereas SNB2 (nZ 10) significantly inhibited pain at
1 h, 3 h, 1 d, and 2 d after surgery compared to the control.
Repeated-measures analysis of variance (ANOVA) with post hoc
Bonferroni’s test, #p < 0.05, ##p < 0.01 vs. pre-op baseline
(Pre); one-way ANOVA with post hoc Bonferroni’s test,
*p < 0.05, **p < 0.01 vs. control. No difference was found
between SNB2 and SNB1 at any time point.
Figure 4 Effects of combination of sciatic blockade and
intravenous alfentanil. Rats were subjected to either low-dose
combination (SNB1 followed by IVA50, or SNB1 þ IVA50) or high-
dose combination (SNB2 þ IVA150) before PI. The control rats
received sham blockade and sham injection as shown in Fig. 2
(i.e., Cont, Sham). The low-dose combination (n Z 8) was
surprisingly not efficacious when compared with the control
group, whereas the high-dose combination (n Z 8) produced
a long and strong suppression on postoperative allodynia
compared to the low-dose combination and the sham group at
postoperative 1 h, 3 h, 1 d, and 2 d. One-way ANOVA with post
hoc Bonferroni’s test, *p < 0.05 and ***p < 0.001 for
SNB2þIVA150 vs. control; þþp < 0.01 and þþþp < 0.001 for
SNB2þIVA150 vs. SNB1þIVA 50. No difference was shown
between low-dose combination and the control.
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surgery (Fig. 2). The withdrawal thresholds were increased
from 1.22  0.25 to 4.94  1.25 g at 1 hour and from
2.54  0.40 to 5.27  0.96 g at 3 hours (control vs. SNB2,
both p < 0.01). The early antiallodynic effect was
moderate compared with the strong effect of IVA (as shownFigure 3 Effects of intravenous alfentanil (IVA). Rats were
subjected to either IVA with 150 or 50 mg/kg alfentanil infusion
from tail vain after peri-sciatic injection with saline (i.e.,
IVA150 and IVA50). The control rats received sham blockade
and sham injection as shown in the Fig. 2 (i.e., Cont, Sham).
IVA50 (nZ 9) had significantly mild antiallodynic effect for 3 h
and IVA150 (n Z 9) produced stronger inhibition at the same
period compared to the control and the IVA50 group. One-way
ANOVA with post hoc Bonferroni’s test, *p < 0.05 and
***p < 0.001 for IVA50 and IVA150 vs. control; þþp < 0.01
and þþþp < 0.001 for IVA150 vs. IVA 50.below). The 2% SNB, 1% SNB, and control groups clearly
exhibited a dose-dependent relationship. No statistical
difference in the preoperative baseline thresholds was
found among the groups.Figure 5 A comparison of analgesic effect between the high-
dose combination treatment and two high-dose single treat-
ments. All data are the same as lines in Figs. 2, 3, and 4.
Notably, high-dose combination of SNB and IVA produced
a strong antiallodynic effect over any single treatment and
sham treatment at the early postoperative period (1 and 3
hours); however, the combination did not produce a stronger
effect than any single treatment at the delayed period (1 and 2
d). No synergistic effect of multimodal treatment on post-
incisional allodynia was observed in this treatment profile.
One-way ANOVA with post hoc Bonferroni’s test, *p < 0.05,
**p < 0.01, and ***p < 0.001 for groups vs. control; þ p < 0.05
and þþþp < 0.001 for SNB2þIVA150 vs. SNB2.
Figure 6 In naı¨ve rats, SNB of 2% lidocaine (n Z 5) elicited
parallel motor and sensory blockade [upper and lower panels in
(A)]. (A) The neurobehavioral functions recovered to the pre-
injection level 70 min later, indicating a short-term effect of
SNB. Solid and dotted lines in each box respectively stand for
median and mean values. Data were compared by Friedman’s
test, #p < 0.05 and ##p < 0.01 vs. baseline data (time point:
Pre-SNB). (B) Effect of the intramuscular lidocaine (2%, 0.5 ml)
injection at the back muscles (IM2). No significant difference
was found between the control group (control, Sham, n Z 9)
and the IML group, suggesting that systemic absorption of
lidocaine has no antiallodynic effect at post-PI period.
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surgery
IVA showed an analgesic pattern different from SNB (Fig. 3).
Both the low-dose (IVA 50 mg/kg) and high-dose (IVA 150 mg/
kg) groups induced a significant reduction in postoperative
allodynia; however, these effects were not be sustained
after 5 hours. The high-dose group produced a much
stronger antiallodynia for the first 3 hours compared to
the low-dose and control groups. Dose-dependent effects
were observed at 1 and 3 hours. Although after 1 day the
alfentanil-treated groups still had mildly analgesic effect
compared to the control group, it did not reach statistical
significance.
It was also observed that high-dose alfentanil caused
transient trunk rigidity and sigh respiration within the first
3e5 minutes after the start of infusion, and a slightly longer
recovery time in the high-dose group; however, all rats
recovered well within 20 minutes after the end of PI.
Combination of SNB and IVA produced a strong,
long-lasting analgesic effect
When SNB and IVA were administered together, a combined
analgesia was observed (Fig. 4). The high-dose combination
(SNB2 þ IVA150) significantly reversed the postoperative
allodynia at 1 hour, 3 hours, 1 day, and 2 days after incision
when compared with the low-dose combination group
(SNB1 þ IVA50) and the sham control group. Surprisingly,
the low dose combination did not produce any analgesic
effect when compared with the sham group, indicating that
no additive or synergistic effect occurred. To compare the
multimodal combination with the single combination, their
effects were plotted in the same diagram (Fig. 5). Clearly,
the analgesic effect of the high-dose combination was
strong and long-lasting, but apparently not a synergism of
both single treatments. During the early (1e3 hours) post-
operative period, the combination effect was seemingly
addictive; and during the late period (1e2 days), the
combination did not differ much from the SBN2 group.
Altogether, our data demonstrated that the combination of
SNB and IVA treatments was able to improve post-PI allo-
dynia mildly or moderately compared to any single treat-
ment with SNB or IVA.
Lidocaine block did not affect behavioral
evaluations or yield systemic analgesia
The motor and sensory blockades by 2% SNB were examined
in this study (Fig. 6A). SNB completely abolished the thrust
force of the left hind foot and nociceptive reflex to a pinch
at the toe. The recovery of both functions was paralleled
along time, and a full recovery (i.e., to a level of no
statistical difference) in sensory and motor tests occurred
respectively at 60 and 70 minutes after blockade, indicating
that the SBN in this study did not directly interfere with
muscle power in response to von Frey tests conducted at
1.5 hours later (i.e., 30 minutes before plus 1 hour after PI).
In another study, an intramuscular lidocaine injection did
not alter the post-PI withdrawal hypersensitivity (Fig. 6B),
demonstrating that systemic absorbed lidocaine had little
106 Y.-R. Wen et al.contribution to postoperative allodynia and that the
SNB-induced analgesia is mostly a result of conduction
blockade.Discussion
The present study showed that, in a rat incision model,
pretreatment with SNB of 2% lidocaine produced moderate
and prolonged antiallodynic effect for 2 days after surgery,
whereas IVA of 150 mg/kg strongly reduced postincisional
allodynia for only 3 hours. A combination of these two
treatment modes led to a remarkable improvement in
analgesic efficacy, although no long-duration effect was
observed. Notably, no synergistic analgesia was observed
when the two treatments were combined at lower doses.
In the clinical setting, multiple analgesic/anesthetic
techniques were coadministered as a “balanced anes-
thesia” to obtain a better anesthetic quality and to reduce
intra- and postoperative pain.4,16 Because pain is a dynamic
process involving multiple sensitizing processes,17 wide
variations in types of surgery, personal sensitivity to pain,
psychocognitive differences, and individual pharmacolog-
ical responses altogether confound the ultimate analgesic
efficacy. Different degrees of success were shown among
studies even though the combination protocols were the
same. Moreover, postoperative patient-controlled anal-
gesia with morphine has been recognized to be problematic
in terms of tolerance, dependence, and opioid-induced
hyperalgesia.18 As a result, clinical investigators have
begun to examine the additional benefits of combining
nonopioid analgesics or conduction blockades with local
anesthesia, regional blocks, or spinal anesthesia.6 With the
increasing popularity of ultrasound-guided techniques,
nerve blocks have become safe and are widely used as
routine anesthetic approaches,19,20 especially for lower
limb surgery.20,21 Because there is no formulated protocol to
suggest any standardized combination for individual surgical
pain, our findings from a PI model in rats can directly
generate informative and comprehensive implications to
clinical studies.
A particular finding in this study is that the short-duration
SNB produced a long-lasting after-effect on postincisional
allodynia. In the 2% lidocaine group, SNB first suppressed
immediate postoperative pain for 3 hours and sustained the
antiallodynic effect for 2 days. Our finding is compatible
with many clinical experiences in that regional anesthesia
attenuated postoperative pain far outlasting the anesthetic
duration. It is generally accepted that conduction anes-
thesia, in addition to its temporal blockade of intra-
operative nociceptive impulses to dorsal root ganglia, also
preempts the activation of spinal N-methyl-D-aspartate
receptors and inhibits the development of central sensiti-
zation.4,17 Therefore, a short-acting agent can produce
acute analgesia by itself, and prolonged effect through
sustained inhibition on neuronal hypersensitivity. This
biphasic effect has been shown with evidence of Fos
expression in neuropathic pain and allodynic behaviors in
a back incision pain model.14,22
Beyond behavioral observations, various molecular
changes may underlie the sensitizations. In our study as
well as in other previous studies, microglial activation isfound to be involved in incisional pain development,9,23e25
and p38 activation in spinal microglia plays a key role in the
regulation of important nociceptive downstream signaling
processes.9,23,26 We found that pretreatment with p38
inhibitor effectively prevented post-PI mechanical allody-
nia9; however, preemptive nerve blockade with bupiva-
caine could only prevent, but not reverse, spinal p38
phosphorylation and nerve injury-induced hypersensi-
tivity.27 Because phosphorylation of p38 (p-p38) within
microglia has been suggested as a hallmark of the devel-
opment process in central nociceptive sensitization,9 it is
rational to assume that pretreatment with short-acting
SNB could preemptively inhibit p-p38 induction by
surgery to facilitate the antiallodynic effect for 2 days. A
more recent study further suggested a long-lasting anal-
gesic effect by lidocaine through attenuation of proin-
flammatory cytokine production.28 Nevertheless, this
inhibitory effect of lidocaine may have been too weak in
this study since no analgesia was observed via intramus-
cular lidocaine injection.
In light of the above-mentioned complexities, it is not
surprising that contradictory results were reported. Wound
infiltration with 1% bupivacaine in Pogatzki et al’s study29 or
SNB with 0.5% bupivacaine in Ririe et al’s study30 was not
able to reduce postincisional allodynia longer than 3 hours.
Both of these studies might be less effective compared to
the present study in that first, the local infiltration used by
Pogatzki et al is not the same as the nerve blockade used in
this study, and second, the block technique in Ririe et al’s
study is a blind injection. Taken together, an important
implication from these studies is that although transmission
blockade can prevent incision-induced allodynia, its
effectiveness may critically depend on minor differences in
pain origins, blockade time, and blockade quality.
Other factors can also influence the SNB efficacy. For
example, first, transmission blockade cannot completely
impede spinal neurons from reactions to all afferent
impulses. Lidocaine cannot sufficiently block action poten-
tials in all types of sensory fibers (myelinated Ab, Ad, and
unmyelinated C fibers), and spontaneous ectopic firing can
still be generated proximal to the blockade site.31 Second,
the medial aspect of the plantar paw near the heel, the area
where von Frey fibers are stimulated, is innervated by the
tibial nerve, a branch of the sciatic nerve. However, the
border adjacent to the medial foot is also innervated by
the saphenous nerve, a branch of the femoral nerve. It is
possible that SNB did not abolish the transmission through
the saphenous nerve and thus the incision-induced periph-
eral sensitization at saphenous nerve could escape the
effect of 2% SNB. These two reasons may explain the low
efficacy of SNB at the early postoperative period.
In this study, the short-acting alfentanil induced a reliable
and dose-dependent peri-operative analgesia for 3 hours;
however, increasing the dose did not produce a prolonged
effect over 1 day. In short, no preemptive effect was
observed. Such result is not surprising because opioid-
induced long-term analgesia has been questioned, espe-
cially when high-potent or high-dose opioids are used. For
example, morphine and D-Ala2-NMe-Phe4-Glyol5-enkephalin
strongly attenuated the formalin-induced spinal Fos expres-
sion or neuronal firing spikes at the second phase of hyper-
algesia when given before, but not after, formalin
Multimodal analgesia for incision pain 107injection.32,33 In contrast, high doses of alfentanil15 or
morphine34 were reported to have no late-phase analgesia in
the same protocol. Moreover, acute tolerance35,36 and
opioid-induced hypersensitivity37 may occur after a rapid
alfentanil administration by activating postsynaptic N-
methyl-D-aspartate receptors and attenuating their long-
term effect. Furthermore, a growing body of evidence has
proved that microglia possess opioid receptors. Chronic
morphine administration can activate spinal microglia to
increase intracellular p-p38 and to antagonize the original
morphine analgesia via the simultaneous releases of proin-
flammatory mediators.38e40 It is thus presumed that SNB
before PI could inhibit microglial p-p38 to prolong anti-
allodynia, whereas IVA might sensitize the spinal glial system
to counteract the production of long-lasting analgesia. Taken
together, these theories can explain, at least partially, why
IVA has such a good, short analgesia, and why IVA and SNB
combination did not exhibit an expected strong-and-long
analgesia.
In this study, the combination of IVA and SNB showed an
additive-like analgesic effect from the individual action of
two single treatments, especially at the first 3 post-
operative hours. Disappointingly, there was no evidence
indicating that an additive or synergistic effect was
produced by the combination treatment during the delayed
period (days 1 and 2 in this study). Usually, isobolographic
analysis is used to confirm pharmacological addition or
synergism,41 but it is impossible to perform this analysis for
lack of sufficient dose-dependent data. However, the
combination treatment used in the current study is clearly
not a synergism because, first, the low-dose combination
did not produce a significant analgesia, and second, instead
of showing a stronger effect, the high-dose combination
group contrarily displayed weaker effects at 1 day and 2
days compared to those of the SNB group.
Although no synergistic effect is observed in this study,
we cannot exclude the possibilities that it may happen in
other pain models (such as inflammatory pain or different
surgical pains), pain characters (spontaneous pain or
thermal pain), or analgesic combinations (such as opioid
plus spinal block). Accordingly, we suggest that, first,
a combination of two or more effective treatments does
not guarantee synergistic effects on all kinds of pain
perception; second, multimodal analgesia for post-
operative pain should be carefully judged and formulated;
and third, intraopertative neural blockade may be more
important than intraoperative opioids for the optimal
control of persistent postoperative pain hypersensitivity. A
vast number of preclinical studies to clarify the individual
efficacies and mechanistic interactions among distinct
combinations are still required to avoid too much waste of
medical resources through empirical trials.
In conclusion, this study demonstrated that pretreat-
ment with multimodal analgesia is superior to single or no
pretreatment in attenuating postoperative allodynia. It is
also suggested that coadministration of mechanism-
independent protocols may interactively act on nocicep-
tive cascades to generate synergistic or even antagonizing
effects. More clinical and mechanistic investigations are
necessary to determine the optimal combination protocols
for a better postoperative pain management.Acknowledgments
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